<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02867787</url>
  </required_header>
  <id_info>
    <org_study_id>P13/09_ Botox</org_study_id>
    <nct_id>NCT02867787</nct_id>
  </id_info>
  <brief_title>Study of the Treatment of Tendinopathy Unruptured of Rotator Cuff by Intramuscular Injection of Botulinum Toxin</brief_title>
  <acronym>Botox shoulder</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Versailles Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Versailles Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Botulinum toxin is used in musculoskeletal therapy routinely for 15 years. This is one of the
      most potent neurotoxins. It comes in 7 serotypes (A to G).Therapeutic application of
      botulinum toxin are mainly based on its ability to block the neuromuscular transmission by
      preventing the release of acetylcholine, creating paralysis muscle relative and reversible.

      It has been used in the treatment of cervical dystonia, migraine headaches, and an
      antinociceptive effect. The analgesic effect occurred even prior to the release muscular.
      Several randomized studies have been published about it. The investigators assume that
      intramuscular injection of botulinum toxin is effective in the treatment of tendinopathy
      rotator cuff.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">September 2016</completion_date>
  <primary_completion_date type="Anticipated">September 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Significant improvement in shoulder pain objectified by analogy Visual Scale (VAS) in patients with unruptured tendinopathy of the rotator cuff impingement, debilitating, lasting for more than 3 months and resistant to usual medical treatment.</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Significant improvement in life quality : functional clinical scores (Constant, ASES, Oxford)</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Tendinopathy Rotator Cuff</condition>
  <arm_group>
    <arm_group_label>Botox arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>intramuscular injection of botulinum toxin</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Botox arm</intervention_name>
    <arm_group_label>Botox arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signed consent

          -  Active social care

          -  Compliant patient with protocol

          -  Patient more than 18 years

          -  Positive Neer Test

        Exclusion Criteria:

          -  Prior study exclusion period

          -  Protected patient

          -  Study refusal

          -  Deficient patient

          -  Rheumatoid arthritis, osteoarthritis, chondrocalcinosis.

          -  Microcrystalline arthritis.

          -  Active infection .

          -  History of hypersensitivity reaction during a previous injection of botulinum toxin

          -  Bilateral involvement

          -  Neurological deficit

          -  Depression

          -  History of shoulder surgery

          -  Pregnant or breast feeding women

          -  Systemic disease (diabeta, vascularitis)

          -  Known neurological disease

          -  Intraarticular associate disease

          -  Acromioclavicular associate disease

          -  Myasthenia

          -  Botulinum toxin is not recommended in combination with aminoglycosides
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pujol Nicolas, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CH Versailles</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Morisset Laure</last_name>
    <email>lmorisset@ch-versailles.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CH Versailles</name>
      <address>
        <city>Le CHESNAY</city>
        <zip>78150</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pujol Nicolas, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Morisset Laure</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 11, 2016</study_first_submitted>
  <study_first_submitted_qc>August 15, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 16, 2016</study_first_posted>
  <last_update_submitted>August 17, 2016</last_update_submitted>
  <last_update_submitted_qc>August 17, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 18, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Versailles Hospital</investigator_affiliation>
    <investigator_full_name>Nicolas Pujol</investigator_full_name>
    <investigator_title>Investigator coordinator</investigator_title>
  </responsible_party>
  <keyword>Shoulder Joint</keyword>
  <keyword>A02.835.583.748</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tendinopathy</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Botulinum Toxins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

